Heartflow stock jumps 16% as AI cardiac diagnostics revenue soars 48% and guidance rises
Heartflow stock surged 16.1% in after-hours trading after the AI-powered diagnostics company posted Q2 revenue of $64.1 million, up 48% year-over-year, crushing Wall Street expectations. The medical technology company raised its full-year 2026 revenue guidance to $246-250 million, signaling strong adoption of its coronary artery disease platform.